Liposomal formulation increases local delivery of amphotericin from bone cement: A pilot study infection

Clinical Orthopaedics and Related Research

Volumn 470, Issue 10, 2012, Pages 2671-2676

  Cunningham, Brian ^a   McLaren, Alex C ^a,b   Pauken, Christine ^b   McLemore, Ryan ^a,b  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^b Arizona State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; AMPHOTERICIN B LIPID COMPLEX; AMPHOTERICIN B LIPID COMPLEX BONE CEMENT; AMPHOTERICIN DEOXYCHOLATE; AMPHOTERICIN DEOXYCHOLATE BONE CEMENT; BONE CEMENT; LIPOSOME; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; CANDIDA ALBICANS; COMPRESSIVE STRENGTH; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; ELUTION; FIXATION DEVICE; FUNGUS GROWTH; GROWTH INHIBITION; LIPOSOMAL DELIVERY; NONHUMAN; PILOT STUDY; PRIORITY JOURNAL;

EID: 84866421080     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-012-2317-4     Document Type: Conference Paper

References (11)

1. Alak A, Moy S, Bekersky I. A high-performance liquid chromatographic assay for the determination of amphotericin B serum concentrations after the administration of AmBisome, a liposomal amphotericin B formulation. Ther Drug Monit. 1996;18:604-609. (Pubitemid 26330484)
2. Butler WT. Pharmacology, toxicity, and therapeutic usefulness of amphotericin B. JAMA. 1966;195:371-375.
3. CLSI. M27-A2: Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved StandardSecond Edition. Wayne, PA, USA: Clinical and Laboratory Standards Institute; 2002:22.
4. Goss B, Lutton C, Weinrauch P, Jabur M, Gillett G, Crawford R. Elution and mechanical properties of antifungal bone cement. J Arthroplasty. 2007;22:902-908. (Pubitemid 47364774)
5. Harmsen S, McLaren AC, Pauken C, McLemore R. Amphotericin B is cytotoxic at locally delivered concentrations. Clin Orthop Relat Res. 2011;469:3016-3021.
6. Hong Y, Ramzan I, McLachlan AJ. Hepatobiliary disposition of liposomal amphotericin B in the isolated perfused rat liver. J Pharm Sci. 2005;94:169-176. (Pubitemid 40116380)
7. Kweon C, McLaren AC, Leon C, McLemore R. Amphotericin B delivery from bone cement increases with porosity but strength decreases. Clin Orthop Relat Res. 2011;469:3002-3007.
8. Marra F, Robbins GM, Masri BA, Duncan C, Wasan KM, Kwong EH, Jewesson PJ. Amphotericin B-loaded bone cement to treat osteomyelitis caused by Candida albicans. Can J Surg. 2001;44:383-386. (Pubitemid 32954712)
9. Morris S, Nicholls PJ. An evaluation of optical density to estimate fungal spore concentrations in water suspensions. Phytopathology. 1978;68:1240-1242.
10. Sealy PI, Nguyen C, Tucci M, Benghuzzi H, Cleary JD. Delivery of antifungal agents using bioactive and nonbioactive bone cements. Ann Pharmacother. 2009;43:1606-1615.
11. Tancréde P, Barwicz J, Jutras S, Gruda I. The effect of surfactants on the aggregation state of amphotericin B. Biochim Biophys Acta. 1990;1030:289-295.